We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Raffi B. Papazian
Raffi B. Papazian
Products
PRODUCTS
MED-EL Elektromedizinische Gereate, Gmbh
Raffi B. Papazian
Price:
$117.00
View
Premier Medical Manufacturing
Raffi B. Papazian
Price:
$117.00
View
Safe-Tec Clinical Products, LLC
Raffi B. Papazian
Price:
$117.00
View
Aspire Bariatrics, Inc.
Raffi B. Papazian
Price:
$117.00
View
Martech Medical Products, Inc.
Edwin L. Hobbs
and
Raffi B. Papazian
Price:
$117.00
View
Medical Products Laboratories, Inc.
Junho Pak
,
Raffi B. Papazian
, and
Deborah J. Parris
Price:
$117.00
View
Hearing Lab Technology, LLC
Raffi B. Papazian
Price:
$117.00
View
Upcoming Events
23
Apr
Managing Data and Documentation for FDA Inspections and Remote Assessments
25
Apr
A Masterclass on Effective 483 Responses
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
30
May
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Eugia Pharma Gets Three 483s Since January, Following Inspections of Plants in India
Abbott/Thoratec Heartmate LVAS Deaths Result in Class I Recall
EMA Releases Its New Real-World Evidence Capabilities to Researchers
Claims That Cardiac Device Grows New Arteries Get Devicemaker FDA Warning Letter
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More